ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 3 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 2.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $68,576 | -31.4% | 21,633 | +7.5% | 0.00% | – |
| Q2 2023 | $100,016 | +4.4% | 20,124 | +3.7% | 0.00% | – |
| Q1 2023 | $95,826 | -31.3% | 19,398 | -12.5% | 0.00% | – |
| Q4 2022 | $139,518 | -38.0% | 22,181 | +6.2% | 0.00% | -100.0% |
| Q3 2022 | $225,000 | -7.4% | 20,884 | -2.2% | 0.00% | 0.0% |
| Q2 2022 | $243,000 | -8.6% | 21,359 | -26.9% | 0.00% | 0.0% |
| Q1 2022 | $266,000 | -51.5% | 29,221 | -20.5% | 0.00% | 0.0% |
| Q4 2021 | $549,000 | -47.7% | 36,775 | -9.9% | 0.00% | -66.7% |
| Q3 2021 | $1,050,000 | -11.5% | 40,837 | -10.2% | 0.00% | 0.0% |
| Q2 2021 | $1,186,000 | -4.3% | 45,476 | +29.5% | 0.00% | -25.0% |
| Q1 2021 | $1,239,000 | +41.1% | 35,111 | +1.0% | 0.00% | +33.3% |
| Q4 2020 | $878,000 | -22.8% | 34,779 | +15.3% | 0.00% | -40.0% |
| Q3 2020 | $1,137,000 | -4.0% | 30,152 | +9.0% | 0.01% | -16.7% |
| Q2 2020 | $1,184,000 | +204.4% | 27,659 | +38.4% | 0.01% | +100.0% |
| Q1 2020 | $389,000 | -54.4% | 19,992 | -39.1% | 0.00% | -25.0% |
| Q4 2019 | $853,000 | – | 32,842 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $11,310,445 | 15.20% |
| Wildcat Capital Management, LLC | 2,128,370 | $13,387,447 | 5.11% |
| TPG GP A, LLC | 18,716,306 | $117,725,565 | 2.31% |
| EcoR1 Capital, LLC | 4,488,200 | $28,230,778 | 0.86% |
| Coastal Bridge Advisors, LLC | 406,847 | $2,559,068 | 0.73% |
| Kynam Capital Management, LP | 396,378 | $2,493,218 | 0.38% |
| AXQ CAPITAL, LP | 73,052 | $459,497 | 0.32% |
| Pier Capital, LLC | 262,832 | $1,653,213 | 0.27% |
| HARBOR CAPITAL ADVISORS, INC. | 41,801 | $262,928 | 0.26% |
| Woodline Partners LP | 2,921,462 | $18,375,996 | 0.25% |